Yep. The market can't look beyond the previous year's posted revenue and P&L. On that basis the market will book Cellmid's significant and ongoing FY improvements . I expect the September quarterly to include some fat US sales .
cheers
Yep. The market can't look beyond the previous year's posted...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1197315 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 184156 | 3 |
View Market Depth
| Last trade - 09.59am 15/08/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable